CFO Robert Chicoski resigns from GlobeStar Therapeutics effective Aug 8, 2024

GlobeStar Therapeutics Corp

CFO Robert Chicoski resigned all officer roles, including principal financial & accounting officer, effective August 8, 2024.
Resignation was not due to any disagreement with the company.
No successor or interim CFO has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Robert Chicoski

Chief Financial Officer

GlobeStar Therapeutics Corp

Effective: 2024-08-08
Filed: October 28, 2024, 7:59 PM ET

On August 8, 2024, GlobeStar Therapeutics Corporation, a Wyoming corporation (the “Company”) received notice of the resignation of Robert Chicoski as Chief Financial Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Chicoski resigned as Chief Financial Officer at GlobeStar Therapeutics Corp.

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On August 8, 2024, GlobeStar Therapeutics Corporation, a Wyoming corporation (the “Company”) received notice of the resignation of Robert Chicoski as Chief Financial Officer of the Company.

View on SEC.gov

Source: SEC EDGAR

accession 0001161697-24-000423

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.